4xhj - Revision history

OCA at 07:45, 27 September 2023

OCA — Wed, 27 Sep 2023 07:45:48 GMT

←Older revision		Revision as of 07:45, 27 September 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_herpesvirus_3_strain_Oka_vaccine Human herpesvirus 3 strain Oka vaccine]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>		<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_herpesvirus_3_strain_Oka_vaccine Human herpesvirus 3 strain Oka vaccine]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 3.156Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [https://pdbe.org/4xhj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [https://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [https://pdbe.org/4xhj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [https://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>
	</table>		</table>

OCA at 09:59, 19 April 2023

OCA — Wed, 19 Apr 2023 09:59:13 GMT

←Older revision		Revision as of 09:59, 19 April 2023
Line 3:		Line 3:
	<StructureSection load='4xhj' size='340' side='right'caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>		<StructureSection load='4xhj' size='340' side='right'caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Hhv-3 Hhv-3~~] and [~~http~~://en.wikipedia.org/wiki/Human ~~Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_herpesvirus_3_strain_Oka_vaccine Human herpesvirus 3 strain Oka vaccine]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">gH, ORF37 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=341980 HHV-3]), gL, ORF60 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=341980 HHV-3])</td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [https://pdbe.org/4xhj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [https://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [~~http~~://pdbe.org/4xhj PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/GH_VZVO GH_VZVO]] The heterodimer glycoprotein H-glycoprotein L is required for the fusion of viral and plasma membranes leading to virus entry into the host cell. Following initial binding of gD to one of its receptors, membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL. May also be involved in the fusion between the virion envelope and the outer nuclear membrane during virion morphogenesis (By similarity). [[http://www.uniprot.org/uniprot/GL_VZVO GL_VZVO]] The heterodimer glycoprotein H-glycoprotein L is required for the fusion of viral and plasma membranes leading to virus entry into the host cell. Following initial binding, membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL (By similarity).	+	[https://www.uniprot.org/uniprot/GH_VZVO GH_VZVO] The heterodimer glycoprotein H-glycoprotein L is required for the fusion of viral and plasma membranes leading to virus entry into the host cell. Following initial binding of gD to one of its receptors, membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL. May also be involved in the fusion between the virion envelope and the outer nuclear membrane during virion morphogenesis (By similarity).
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 23:		Line 22:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Hhv-3~~]]	+	[[Category: Homo sapiens]]
-	[[Category: Human]]	+	[[Category: Human herpesvirus 3 strain Oka vaccine]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Xing, Y]]	+	[[Category: Xing Y]]
-	~~[[Category: Complex]]~~	+
-	~~[[Category: Neutralization epitope]]~~	+
-	~~[[Category: Viral protein-immune system complex~~]]	+

OCA at 07:03, 29 May 2019

OCA — Wed, 29 May 2019 07:03:43 GMT

←Older revision		Revision as of 07:03, 29 May 2019
Line 1:		Line 1:

	==gHgL of Varicella-zoster virus in complex with human neutralizing antibodies.==		==gHgL of Varicella-zoster virus in complex with human neutralizing antibodies.==
-	<StructureSection load='4xhj' size='340' side='right' caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>	+	<StructureSection load='4xhj' size='340' side='right'caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure with sequence from [http://en.wikipedia.org/wiki/Hhv-3 Hhv-3] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">gH, ORF37 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=341980 HHV-3]), gL, ORF60 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=341980 HHV-3])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [http://pdbe.org/4xhj PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [http://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [http://pdbe.org/4xhj PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [http://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>
	</table>		</table>
Line 22:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Hhv-3]]
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Xing, Y]]		[[Category: Xing, Y]]
	[[Category: Complex]]		[[Category: Complex]]
	[[Category: Neutralization epitope]]		[[Category: Neutralization epitope]]
	[[Category: Viral protein-immune system complex]]		[[Category: Viral protein-immune system complex]]

OCA at 01:53, 10 March 2017

OCA — Fri, 10 Mar 2017 01:53:13 GMT

←Older revision		Revision as of 01:53, 10 March 2017
Line 1:		Line 1:
		+
	==gHgL of Varicella-zoster virus in complex with human neutralizing antibodies.==		==gHgL of Varicella-zoster virus in complex with human neutralizing antibodies.==
	<StructureSection load='4xhj' size='340' side='right' caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>		<StructureSection load='4xhj' size='340' side='right' caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>
Line 4:		Line 5:
	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>		<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [http://www.ebi.ac.uk/pdbsum/4xhj PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [http://pdbe.org/4xhj PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [http://www.ebi.ac.uk/pdbsum/4xhj PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4xhj ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 16:		Line 17:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4xhj" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 12:11, 13 May 2015

OCA — Wed, 13 May 2015 12:11:42 GMT

←Older revision		Revision as of 12:11, 13 May 2015
Line 1:		Line 1:
-	'''~~Unreleased~~ structure'''	+	==gHgL of Varicella-zoster virus in complex with human neutralizing antibodies.==
		+	<StructureSection load='4xhj' size='340' side='right' caption='[[4xhj]], [[Resolution\|resolution]] 3.16Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[4xhj]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XHJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XHJ FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4xhj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xhj OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4xhj RCSB], [http://www.ebi.ac.uk/pdbsum/4xhj PDBsum]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/GH_VZVO GH_VZVO]] The heterodimer glycoprotein H-glycoprotein L is required for the fusion of viral and plasma membranes leading to virus entry into the host cell. Following initial binding of gD to one of its receptors, membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL. May also be involved in the fusion between the virion envelope and the outer nuclear membrane during virion morphogenesis (By similarity). [[http://www.uniprot.org/uniprot/GL_VZVO GL_VZVO]] The heterodimer glycoprotein H-glycoprotein L is required for the fusion of viral and plasma membranes leading to virus entry into the host cell. Following initial binding, membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL (By similarity).
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Varicella-zoster virus (VZV), of the family Alphaherpesvirinae, causes varicella in children and young adults, potentially leading to herpes zoster later in life on reactivation from latency. The conserved herpesvirus glycoprotein gB and the heterodimer gHgL mediate virion envelope fusion with cell membranes during virus entry. Naturally occurring neutralizing antibodies against herpesviruses target these entry proteins. To determine the molecular basis for VZV neutralization, crystal structures of gHgL were determined in complex with fragments of antigen binding (Fabs) from two human monoclonal antibodies, IgG-94 and IgG-RC, isolated from seropositive subjects. These structures reveal that the antibodies target the same site, composed of residues from both gH and gL, distinct from two other neutralizing epitopes identified by negative-stain electron microscopy and mutational analysis. Inhibition of gB/gHgL-mediated membrane fusion and structural comparisons with herpesvirus homologs suggest that the IgG-RC/94 epitope is in proximity to the site on VZV gHgL that activates gB. Immunization studies proved that the anti-gHgL IgG-RC/94 epitope is a critical target for antibodies that neutralize VZV. Thus, the gHgL/Fab structures delineate a site of herpesvirus vulnerability targeted by natural immunity.

-	~~The entry 4xhj is ON HOLD until Paper Publication~~	+	A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL.,Xing Y, Oliver SL, Nguyen T, Ciferri C, Nandi A, Hickman J, Giovani C, Yang E, Palladino G, Grose C, Uematsu Y, Lilja AE, Arvin AM, Carfi A Proc Natl Acad Sci U S A. 2015 Apr 27. pii: 201501176. PMID:25918416<ref>PMID:25918416</ref>

-	~~Authors: Xing~~, Y.	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-		+	</div>
-	~~Description: gHgL~~ of ~~Varicella-zoster virus in complex with human neutralizing antibodies~~.	+	== References ==
-	~~[[Category: Unreleased Structures]]~~	+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Xing, Y]]		[[Category: Xing, Y]]
		+	[[Category: Complex]]
		+	[[Category: Neutralization epitope]]
		+	[[Category: Viral protein-immune system complex]]

OCA at 09:49, 18 March 2015

OCA — Wed, 18 Mar 2015 09:49:14 GMT

←Older revision		Revision as of 09:49, 18 March 2015
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4xhj is ON HOLD	+	The entry 4xhj is ON HOLD until Paper Publication

	Authors: Xing, Y.		Authors: Xing, Y.

OCA: Protected "4xhj" [edit=sysop:move=sysop]

OCA — Wed, 14 Jan 2015 12:42:59 GMT

Protected "4xhj" [edit=sysop:move=sysop]

←Older revision

Revision as of 12:42, 14 January 2015

OCA: New page: '''Unreleased structure''' The entry 4xhj is ON HOLD Authors: Xing, Y. Description: gHgL of Varicella-zoster virus in complex with human neutralizing antibodies. [[Category: Unreleased...

OCA — Wed, 14 Jan 2015 12:42:57 GMT

New page: '''Unreleased structure''' The entry 4xhj is ON HOLD Authors: Xing, Y. Description: gHgL of Varicella-zoster virus in complex with human neutralizing antibodies. [[Category: Unreleased...

New page

'''Unreleased structure'''

The entry 4xhj is ON HOLD

Authors: Xing, Y.

Description: gHgL of Varicella-zoster virus in complex with human neutralizing antibodies.
[[Category: Unreleased Structures]]
[[Category: Xing, Y]]